Kevin Camphausen Selected Research

Kevin Camphausen Research Topics

Disease

127	Neoplasms (Cancer) 01/2022 - 06/2002
31	Glioma (Gliomas) 01/2022 - 09/2003
30	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2009
17	Brain Neoplasms (Brain Tumor) 01/2019 - 04/2005
17	Prostatic Neoplasms (Prostate Cancer) 02/2012 - 12/2003
13	Breast Neoplasms (Breast Cancer) 02/2021 - 02/2006
12	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2006
8	Carcinoma (Carcinomatosis) 06/2022 - 01/2004
5	Disease Progression 02/2021 - 07/2009
4	Triple Negative Breast Neoplasms 10/2015 - 10/2009
3	Radiation Injuries (Radiation Sickness) 01/2022 - 12/2003
3	Stomach Neoplasms (Stomach Cancer) 09/2020 - 01/2012
3	Urinary Bladder Neoplasms (Bladder Cancer) 09/2020 - 08/2006
3	Hypoxia (Hypoxemia) 10/2017 - 04/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016 - 05/2006
3	Vaccinia 08/2008 - 06/2004
2	Melanoma (Melanoma, Malignant) 09/2020 - 07/2011
2	Neoplasm Micrometastasis 10/2015 - 10/2009
2	Hypertension (High Blood Pressure) 10/2014 - 02/2009
2	Paraganglioma (Paragangliomas) 01/2014 - 04/2013
2	Pheochromocytoma 01/2014 - 04/2013
2	Diffuse Intrinsic Pontine Glioma 07/2012 - 07/2012
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2011 - 01/2010
2	Fowlpox 08/2008 - 05/2005
2	Proctitis 01/2008 - 07/2006

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2003
13	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 05/2004
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2006
11	Biological ProductsIBA 12/2021 - 06/2003
11	Pharmaceutical PreparationsIBA 01/2021 - 04/2005
11	Histone Deacetylase InhibitorsIBA 01/2020 - 01/2004
8	Temozolomide (Temodar)FDA LinkGeneric 06/2020 - 02/2008
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020 - 02/2004
7	VaccinesIBA 11/2011 - 06/2004
6	Phosphotransferases (Kinase)IBA 10/2021 - 05/2009
6	CytokinesIBA 01/2021 - 12/2005
6	Histones (Histone)IBA 01/2020 - 09/2004
5	Radiation-Sensitizing AgentsIBA 01/2021 - 02/2008
5	Valproic Acid (Depakote)FDA LinkGeneric 03/2020 - 04/2005
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2004
5	Vorinostat FDA Link 01/2020 - 06/2009
5	Carcinoembryonic AntigenIBA 11/2011 - 06/2004
5	AntigensIBA 08/2008 - 06/2004
4	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2018
4	RNA (Ribonucleic Acid)IBA 09/2020 - 05/2004
4	ChromatinIBA 01/2018 - 01/2004
4	trans-sodium crocetinate (crocetin)IBA 02/2012 - 04/2009
4	Angiogenesis InhibitorsIBA 11/2009 - 05/2003
4	Amifostine (Ethyol)FDA LinkGeneric 01/2008 - 12/2003
3	MicroRNAs (MicroRNA)IBA 02/2021 - 09/2014
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2018 - 02/2009
3	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018 - 07/2015
3	LB100IBA 01/2018 - 07/2015
3	Oxygen (Dioxygen)IBA 10/2017 - 04/2009
3	Coloring Agents (Dyes)IBA 09/2014 - 02/2004
3	Fluorouracil (Carac)FDA LinkGeneric 02/2013 - 08/2011
3	SuspensionsIBA 03/2012 - 07/2006
3	Monoclonal AntibodiesIBA 09/2011 - 06/2005
3	Docetaxel (Taxotere)FDA Link 02/2010 - 02/2006
3	Capecitabine (Xeloda)FDA Link 02/2010 - 06/2007
3	EndostatinsIBA 04/2004 - 01/2004
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2022 - 05/2012
2	Eukaryotic Initiation Factor-4F (EIF4F)IBA 10/2021 - 01/2014
2	Eukaryotic Initiation Factor-4EIBA 10/2021 - 05/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 12/2005
2	A-Form DNA (A-DNA)IBA 10/2019 - 02/2008
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2011
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 12/2005
2	salicylhydroxamic acid (SHAM)IBA 10/2015 - 04/2003
2	Sunitinib (Sutent)FDA Link 10/2014 - 03/2013
2	Polo-Like Kinase 1IBA 09/2013 - 12/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2013 - 01/2012
2	ChemokinesIBA 01/2013 - 07/2011
2	dipinacoline glutamateIBA 07/2012 - 07/2012
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2012 - 12/2005
2	DepsipeptidesIBA 12/2011 - 01/2010
2	Radioisotopes (Radionuclides)IBA 03/2011 - 07/2008
2	Indicators and Reagents (Reagents)IBA 02/2010 - 09/2004
2	Bevacizumab (Avastin)FDA Link 02/2009 - 02/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 08/2008 - 05/2005
2	Fas Ligand Protein (Fas Ligand)IBA 08/2008 - 06/2004
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2008 - 09/2007
2	Cancer VaccinesIBA 09/2007 - 05/2005
2	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 09/2006 - 12/2004
2	entinostat (MS 275)IBA 09/2004 - 01/2004
2	alvocidib (flavopiridol)IBA 07/2004 - 04/2004

Therapy/Procedure

70	Radiotherapy 06/2022 - 04/2003
49	Therapeutics 01/2022 - 06/2002
10	Drug Therapy (Chemotherapy) 01/2020 - 01/2004
9	Immunotherapy 09/2020 - 06/2003
5	Re-Irradiation 12/2021 - 12/2005
5	Aftercare (After-Treatment) 01/2019 - 12/2003
4	Brachytherapy 08/2006 - 08/2004
3	Chemoradiotherapy 06/2022 - 01/2010
2	Craniospinal Irradiation 12/2021 - 09/2011
2	Diet Therapy (Therapy, Diet) 01/2020 - 06/2013
2	Caloric Restriction 07/2014 - 06/2013
2	Injections 01/2010 - 09/2004